ANDERSEN; Peter Hongaard

Patent Applications and Registrations

Patent applications and USPTO patent grants for ANDERSEN; Peter Hongaard.The latest application filed is for "deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia".

Company Profile

4.9.10

ANDERSEN; Peter Hongaard - Farum DK
Andersen; Peter Hongaard - Vaerlose DK
Andersen; Peter Hongaard - Vanlose DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20220119362 - JORGENSEN; Morten ; et al.	2022-04-21
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 11,059,798 - Jorgensen , et al. July 13, 2	2021-07-13
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20200131143 - JORGENSEN; Morten ; et al.	2020-04-30
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 10,501,427 - Jorgensen , et al. Dec	2019-12-10
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20190031631 - JORGENSEN; Morten ; et al.	2019-01-31
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 10,118,907 - Jorgensen , et al. November 6, 2	2018-11-06
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20170158650 - JORGENSEN; Morten ; et al.	2017-06-08
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 9,617,231 - Jorgensen , et al. April 11, 2	2017-04-11
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia App 20160068497 - JORGENSEN; Morten ; et al.	2016-03-10
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 9,216,961 - Jorgensen , et al. December 22, 2	2015-12-22
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia App 20150307458 - JORGENSEN; Morten ; et al.	2015-10-29
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 9,012,453 - Jorgensen , et al. April 21, 2	2015-04-21
Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia Grant 8,575,174 - Jorgensen , et al. November 5, 2	2013-11-05
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20130281436 - JORGENSEN; Morten ; et al.	2013-10-24
Deuterated 1-piperazino-3-phenyl-indanes For Treatment Of Schizophrenia App 20120322811 - JORGENSEN; Morten ; et al.	2012-12-20
GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity App 20090143435 - Ebert; Bjarke ; et al.	2009-06-04
GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity App 20040024038 - Ebert, Bjarke ; et al.	2004-02-05
Compounds with growth hormone releasing properties Grant 5,990,084 - Richter , et al. November 23, 1	1999-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.